ASX Announcement (ASX:AXE) 17 February 2020 International patent...

ASX Announcement (ASX:AXE)
17 February 2020 International patent application filed to commercialise graphene biosensor technology Highlights
• Archer files patent application under the Patent Cooperation Treaty (“International Patent Application”).
• International Patent Application filed to protect and commercialise graphene biosensor technology intellectual property (“IP”).
• Archer maintains 100% ownership of the International Patent Application and related IP.
• The global biosensor market is part of the emerging Medtech industry where patents are important licensable assets and sources of revenue1,2,3.

Archer Materials Limited (“Archer”, the “Company”, “ASX:AXE”) is pleased to announce that the Company has filed a patent application under the Patent Cooperation Treaty (“International Patent Application”), to protect and commercialise its graphene biosensor technology intellectual property (“IP”). Archer is using graphene materials to potentially solve selectivity and detection challenges in biosensing (see Biosensors & Archer’s Graphene Advantage).

Commenting on the Company’s commercial development, Archer CEO, Dr Mohammad Choucair, said: “One of Archer’s key execution priorities to deliver value to our shareholders is to prosecute patents related to the development of graphene-based biosensor technology.”

“Filing an international patent application represents the first step in the commercialisation of the Company’s graphene biosensor technology. Importantly, Archer independently generated the IP, and maintains 100% ownership of this new [Company] asset, that has the potential to positively disrupt the emerging Medtech industry”.

Archer filed a patent application under the Patent Cooperation Treaty (“PCT”) with the World International Patent Organization (“WIPO”) via IP Australia in compliance with the application process deadline for lodgement of February 15, 2020, thereby maintaining the priority date established from the Company’s provisional patent application (ASX Ann. Feb 19, 2019).

Filing a PCT application will allow Archer to decide which countries to have patent protection in and will allow for international protection, which can last for up to 20 years†. The International Patent Application and underlying IP is 100% owned by Archer and the inventor of the IP is Archer CEO, Dr Mohammad Choucair.

Excellent!